Global Liver Disease Management Market

Report ID : 1447 | Published : 2022-11-15 | Pages: | Format: PDF/EXCEL

The market size of the Global Liver Disease Management Market  in the year 2021 is valued at 23.03 billion and is predicted to reach 39.62 billion by the year 2030 at an 6.40% CAGR during the forecast period.

Liver disease can be acquired (genetic) or caused by liver-harming causes such as viruses (hepatitis A, B, and C) and alcohol usage. Obesity has been connected to liver disease as well. The liver is required for food digestion as well as to regulate the toxicity of chemicals in the body. One of the primary key factors driving the market's growth is the world's growing geriatric population, which is susceptible to various chronic diseases, including liver disease. Changing dietary habits and sedentary lifestyles are driving market expansion. The rising prevalence of fatty liver disease due to excessive cholesterol, obesity, hypertension (high blood pressure), and diabetes is boosting market growth.

Furthermore, significant technological breakthroughs, such as the creation of the bioartificial liver, are driving market expansion. It replaces liver functions with regenerated liver cells and is commonly utilized in individuals with acute liver failure. By this, the quick acceptance of anti-viral medications, safe and efficient in suppressing the hepatitis B virus and lowering the risk of developing cirrhosis and hepatocellular carcinoma, is favorably impacting the market growth. Aside from that, increased research and development (R&D) efforts, significant increases in the healthcare industry, and implementation of different government measures to enhance public health are producing a good outlook for the market.

Market Segmentation:

The liver disease management market is segmented on diagnosis, treatment and end-use. Based on the diagnosis, the market is segmented into endoscopy, imaging, biopsy,  and others. Based on treatment, liver disease management market is segmented into anti-viral drugs, targeted therapy, chemotherapy and others. Based on end-use, the liver disease management market is segmented into clinics, hospitals, diagnostics laboratories and others.

Based on the diagnosis, the imaging segment is accounted as a major contributor to the liver disease management market.

The imaging segment is expected to hold a significant share of the market due to an increase in the number of initiatives launched by key companies in the liver disease diagnostics market to create new imaging techniques. Laboratory tests are performed using urine, blood, and other fluid samples to diagnose liver function. Ultrasound, X-ray, Magnetic Resonance Imaging (MRI) scan, Computed Tomography (CT) scan, and more imaging procedures are available.

The hospital segment witnessed growth at a rapid rate.

Hospitals grabbed the highest revenue share, and it is anticipated that they will continue to hold that position during the anticipated time. Since most patients rely on hospitals with diagnostic testing instruments, hospitals give excellent treatment to patients and enable early identification and diagnosis, enhancing the market for liver disease diagnostics. Furthermore, continued healthcare infrastructure development is expected to improve existing hospital facilities.

The Asia Pacific liver disease management market holds a significant revenue share in the region.

The Asia Pacific Liver disease management market is expected to register the highest market share in revenue in the near future. The growing elderly population and increased awareness of the importance of regular check-ups are driving the expansion of the market for liver disease diagnostics in this area. Furthermore, it is expected that regulatory approval of innovative technologies that can be combined with imaging systems would boost regional growth. In addition, North America is projected to grow rapidly in the global Liver disease management market. High R&D investments and prominent players are projected to drive the growth of the region's market for liver disease diagnostics. Furthermore, organizations that supply patients with information about disease diagnosis are projected to boost the expansion of the market for liver disease diagnostics.

Competitive Landscape

The key players in the Liver disease management market have shifted their focus toward product manufacturing and are initiating significant strategies such as mergers, acquisitions, and joint ventures of major and domestic players to enhance their product portfolio and strengthen their global market footprint. Some major key players in the liver disease management market are Abbott, AbbVie Inc., Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Astellas Pharma Inc, Lilly, Merck & Co., Inc, Pfizer Inc., Novartis AG, Johnson & Johnson Private Limited.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Liver Disease Management Market Snapshot

Chapter 4. Global Liver Disease Management Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Diagnosis Estimates & Trend Analysis

5.1. by Diagnosis & Market Share, 2019 & 2030

5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Diagnosis:

5.2.1. Endoscopy

5.2.2. Imaging

5.2.3. Biopsy

5.2.4. Others

Chapter 6. Market Segmentation 2: by Treatment Estimates & Trend Analysis

6.1. by Treatment & Market Share, 2019 & 2030

6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Treatment:

6.2.1. Anti-Viral Drugs

6.2.2. Targeted Therapy

6.2.3. Chemotherapy

6.2.4. Others

Chapter 7. Market Segmentation 3: by End-Use Estimates & Trend Analysis

7.1. by End-Use & Market Share, 2019 & 2030

7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by End-Use:

7.2.1. Clinics

7.2.2. Hospitals

7.2.3. Diagnostics Laboratories

7.2.4. Others

Chapter 8. Liver Disease Management Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Liver Disease Management Market Revenue (US$ Million) Estimates and Forecasts by Diagnosis, 2022-2030

8.1.2. North America Liver Disease Management Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2022-2030

8.1.3. North America Liver Disease Management Market revenue (US$ Million) by End-Use, 2022-2030

8.1.4. North America Liver Disease Management Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030

8.2. Europe

8.2.1. Europe Liver Disease Management Market revenue (US$ Million) by Diagnosis, 2022-2030

8.2.2. Europe Liver Disease Management Market revenue (US$ Million) by Treatment, 2022-2030

8.2.3. Europe Liver Disease Management Market revenue (US$ Million) by End-Use, 2022-2030

8.2.4. Europe Liver Disease Management Market revenue (US$ Million) by country, 2022-2030

8.3. Asia Pacific

8.3.1. Asia Pacific Liver Disease Management Market revenue (US$ Million) by Diagnosis, 2022-2030

8.3.2. Asia Pacific Liver Disease Management Market revenue (US$ Million) by Treatment, 2022-2030

8.3.3. Asia-Pacific Liver Disease Management Market revenue (US$ Million) by End-Use, 2022-2030

8.3.4. Asia Pacific Liver Disease Management Market revenue (US$ Million) by country, 2022-2030

8.4. Latin America

8.4.1. Latin America Liver Disease Management Market revenue (US$ Million) by Diagnosis, 2022-2030

8.4.2. Latin America Liver Disease Management Market revenue (US$ Million) by Treatment, 2022-2030

8.4.3. Latin America Liver Disease Management Market revenue (US$ Million) by End-Use, 2022-2030

8.4.4. Latin America Liver Disease Management Market revenue (US$ Million) by country, 2022-2030

8.5. Middle East & Africa

8.5.1. Middle East & Africa Liver Disease Management Market revenue (US$ Million) by Diagnosis, 2022-2030

8.5.2. Middle East & Africa Liver Disease Management Market revenue (US$ Million) by Treatment, 2022-2030

8.5.3. Middle East & Africa Liver Disease Management Market revenue (US$ Million) by End-Use, 2022-2030

8.5.4. Middle East & Africa Liver Disease Management Market revenue (US$ Million) by country, 2022-2030

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. Abbott

9.2.2. AbbVie Inc.

9.2.3. F. Hoffmann-La Roche Ltd.

9.2.4. Bristol-Myers Squibb Company

9.2.5. Astellas Pharma Inc.

9.2.6. Lilly

9.2.7. Merck & Co., Inc.

9.2.8. Pfizer Inc.

9.2.9. Novartis AG

9.2.10. Johnson & Johnson Private Limited

9.2.11. Other Prominent Players

By Diagnosis

  • Endoscopy
  • Imaging
  • Biopsy
  • Others

By Treatment

  • Anti-Viral Drugs
  • Targeted Therapy
  • Chemotherapy
  • Others

By End-Use

  • Clinics
  • Hospitals
  • Diagnostics Laboratories
  • Others

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients